Provider: Ingenta Connect Database: Ingenta Connect Content: application/x-research-info-systems TY - ABST AU - Cheng, Xian-Chao AU - Wang, Qiang AU - Fang, Hao AU - Xu, Wen-Fang TI - Role of Sulfonamide Group in Matrix Metalloproteinase Inhibitors JO - Current Medicinal Chemistry PY - 2008-02-01T00:00:00/// VL - 15 IS - 4 SP - 368 EP - 373 KW - Matrix metalloproteinases KW - hydrogen bond KW - sulfonamide KW - gauche conformation KW - inhibitors KW - zinc binding group N2 - Sulfonamide hydroxamates were designed and synthesized as efficient matrix metalloproteinase (MMP) inhibitors since the discovery of CGS 27023A in 1994. The sulfonamide group was incorporated in the inhibitor to improve the enzyme-inhibitor binding, not only by forming hydrogen bonds to the enzyme but also by properly directing the hydrophobic substituent to the S1' pocket and enabling it to plunge in deeply. Some researchers even presumed that the sulfonamide group, together with the zinc binding group (ZBG), coordinated the zinc ion within the MMP active site. This review will illustrate the role of the sulfonamide group in MMP inhibitors.





UR - https://www.ingentaconnect.com/content/ben/cmc/2008/00000015/00000004/art00005 M3 - doi:10.2174/092986708783497300 UR - https://doi.org/10.2174/092986708783497300 ER -